Our results indicate that the increased basal levels of RhoA and PKC signaling constitute independent mechanisms of MARCKS activation in BRAFi-R melanoma cells and that combined inhibition of RhoA and PKC signaling is an effective means of inhibiting MARCKS activity. Here, MARCKS is linked to melanoma.